Back

Prognostic implication of neutrophil-lymphocyte ratio (NLR) in myocarditis: results from a multicentre, multinational study.

28 August 2022 (10:35 - 10:45)
Organised by:
Congress Presentation Part of: Myocarditis: still many open questions Myocarditis ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Matthew Sadler

King's College Hospital, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Impact of myocardial injury on mortality and adverse events in hospitalized patients with influenza: a prospective cohort study
Doctor A. Valotta (Lugano, CH)
Abstract Slides Video
Presentation thumbnail
Prevalence and characteristics of abnormalities on cardiac MRI in unselected patients after recovery from acute SARS-CoV-2 infection and correlation with markers of immunity and coagulation: the Study
Doctor R. Colleran (Dublin 7, IE)
Abstract Slides Video
Presentation thumbnail
Genetic characterization of biopsy-proven myocarditis: a pilot study
Doctor M. Bueno Marinas (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Role of immunosuppression in patients with lymphocytic myocarditis and myocardial parvovirus B19 with or without human herpesvirus 6 co-presence
Doctor A. Elsanhoury (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
SARS-CoV-2 vaccination and myocarditis in a highly vaccinated New Zealand population
Doctor C. Greer (Christchurch, NZ)
Abstract Slides Video

Access the full session

Session thumbnail
Myocarditis: still many open questions

The Event

Event poster

ESC Congress 2022

28 August 2022 10:35 CET
You may be interested in
thumbnail
Congress Presentation
Neutrophil to lymphocyte ratio as a predictor of left ventricle function and long-term mortality in patients after myocardial infarction.
thumbnail
Congress Presentation
Prognostic value of neutrophil-to-lymphocyte ratio and cardiac troponin I in patients with immune checkpoint inhibitors-related myocarditis
thumbnail
Congress Session
Myocarditis management in 2025 from a global perspective

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources